by MASA | Apr 23, 2024 | Drug Updates, News
The U.S. Food and Drug Administration (FDA) has provided an emergency use authorization (EUA) for a new medicine called Pemgarda™ (pemivibart), aimed at preventing COVID-19 in certain high-risk individuals. This medication is specifically designed for those who are...
by MASA | Mar 31, 2024 | Drug Updates
US FDA approved of XHANCE as the first and only medication for adults with chronic rhinosinusitis without nasal polyps. It is a fluticasone propionate nasal spray which uses the Exhalation Delivery System to enable topical steroid to the inflamed areas and is proven...
by MASA | Jan 19, 2024 | Immune System, Immunodeficiency Hypogammaglobulinemia, News, Patient Opportunity, Rare Diseases
CIIC Annual Patient Scholarship: Empowering PIDD and Rare Disease Patients The CIIC (Coalition of Immunology and Allergy Clinics) is proud to announce the continuation of its Annual Patient Scholarship program, initiated in 2021. This unique scholarship is...
by MASA | Jan 15, 2024 | Hereditary Angioedema, immune system disorders, News, Rare Diseases
Dr. Dareen Siri was invited to share her experience in “Simplifying the Science, the Root Cause of HAE”, which is part one of the HAE podcast series where in each episode is a conversation with another HAE expert trying to dig into some of the nuances of hereditary...
by MASA | Mar 14, 2023 | News
The first patient in the VITESSE clinical trial was screened in Normal, Illinois, by the research team led by Principal Investigator Dr. Dareen Siri MD FAAAAI, FACAAI. Dr. Siri is among the Principle Investigators leading clinical trials across United States, Canada,...
by MASA | Feb 2, 2022 | News
MASA news: Gabriel Delgado, senior at Illinois Math and Science Academy Class of 2022, who took part in the IMSA business mentorship program hosted by Dr Siri and MASA/SWIA, was chosen for an oral poster presentation to share his research project at the 2022 American...
